Detection of telomerase activity in biopsy samples of colorectal cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 4, 1999, Pages 328-332

  Fang, Dian Chun ^b   Young, Joanne ^a   Luo, Yuan Hui ^a   Lu, Rong ^c   Jass, Jeremy ^a,c  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Bancroft Centre   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Colorectal cancer; Polymerase chain reaction based assay; Telomerase activity

Indexed keywords

DNA; TELOMERASE;

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR BIOPSY;

EID: 0033371752     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01862.x     Document Type: Article

References (40)

1. 1 Allshire RC, Dempster M, Hastie ND. Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res. 1989; 17: 4611-27.
2. 2 De Lange T, Shiue L, Myers RM et al. Structure and variability of human chromosome ends. Mol. Cell. Biol. 1990; 10: 518-27.
3. 3 Feng JL, Funk WD, Wang SS et al. The RNA component of human telomerase. Science 1995; 269: 1236-41.
4. 4 Harley CB, Futchter AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-60.
5. 5 Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990; 346: 866-8.
6. 6 Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
7. 7 Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 1995; 55: 2533-6.
8. 8 Bednarek A, Budunora I, Slaga TJ, Aldaz MC. Increased telomerase activity in mouse skin premalignant progression. Cancer Res. 1995; 55: 4566-9.
9. 9 Broccoli D, Young JW, De Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl Acad. Sci. USA 1995; 92: 9082-6.
10. 10 Kyo S, Takakura M, Ishikawa H et al. Application of telomerase assay for the screening of cervical lesions. Cancer Res. 1997; 57: 1863-7.
11. 11 Yoshida K, Sugino T, Tahara H et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997; 79: 362-9.
12. 12 Hiyama E, Yokoyama T, Tatsumoto N et al. Telomerase activity in gastric cancer. Cancer Res. 1995; 55: 3258-62.
13. 13 Tahara H, Nakanishi T, Kitamoto M et al. Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res. 1995; 55: 2734-6.
14. 14 Hiyama K, Hiyama E, Ishioka S et al. Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl Cancer Inst. 1995; 87: 895-902.
15. 15 Yashima K, Litzky LA, Kaiser L et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res. 1997; 57: 2373-7.
16. 16 Avilion AA, Piatyszek MA, Gupta J, Shay JVV, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 1996; 56: 645-50.
17. 17 Meijer GA, Baak JPA, Talbot IC, Atkin WS, Meuwissen SGM. Predicting the risk of metachronous colorectal cancer in patients with rectosigmoid adenomas using quantitative pathological features: A case-control study. J. Pathol. 1998; 184: 63-70.
18. 18 Nusko G, Mansmann U, Partzsch U et al. Invasive carcinoma in colorectal adenoma: Multivariate analysis of patient and adenoma characteristics. Endoscopy 1997; 29: 626-31.
19. 19 Li ZH, Salovaara R, Aaltonen LA, Shibata D. Telomerase activity is commonly detected in hereditary nonpolyposis colorectal cancers. Am. J. Pathol. 1996; 148: 1075-9.
20. 20 Engelhardt M, Drullinsky P, Guillem J, Moore MAS. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin. Cancer Res. 1997; 3: 1931-41.
21. 21 Engelhardt M, Albanell J, Drullinsky P et al. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancer of the prostate, colon, and sarcoma. Clin. Cancer Res. 1997; 3: 1849-57.
22. 22 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annals Biochem. 1976; 72: 248-54.
23. 23 Hiyama K, Hirai Y, Kyoizumi et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 1995; 155: 3711-5.
24. 24 Wright WE, Piatyszk MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 1996; 18: 173-9.
25. 25 Greider CW. Telomerase activity, cell proliferation, and cancer. Proc. Natl Acad. Sci. USA 1998; 95: 90-2.
26. 26 Tahara H, Kuniyasu H, Yokozaki H et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin. Cancer Res. 1995; 1: 1245-51.
27. 27 Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal tumor development. N. Engl. J. Med. 1988; 319: 525-32.
28. 28 Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997; 386: 623-7.
29. 29 Cheng AJ, Tang R, Wang JY, See LC, Wang TCV. Possible role of telomerase activation in the cancer predisposition of patients with hereditary nonpolyposis colorectal cancers. J. Natl Cancer Inst. 1998; 90: 316-21.
30. 30 Yoshida K, Sugino T, Goodison S et al. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br. J. Cancer 1997; 75: 548-53.
31. 31 Umbricht CB, Saji M, Westra WH, Udelsman R, Zeiger MA, Sukumer S. Telomerase activity: A marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res. 1997; 57: 2144-7.
32. 32 Takahashi C, Miyagawa I, Kumano S, Oshimura M. Detection of telomerase activity in prostate cancer by needle biopsy. Eur. J. Urol. 1997; 32: 494-8.
33. 33 Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T, Kajiyama G. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int. J. Cancer 1997; 74: 141-7.
34. 34 Califano J, Ahrendt SA, Meininger G, Westra WH, Koch WH, Sidransky D. Detection of telomerase activity in oral rines from head and neck squamous cell carcinoma patients. Cancer Res. 1996; 56: 5720-2.
35. 35 Kavaler E, Landman J, Chang YL, Droller MJ, Liu BCS. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer 1998; 82: 708-14.
36. 36 Heine B, Hummel M, Muller M, Heicappell R, Miller K, Stein H. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. J. Pathol. 1998; 184: 71-6.
37. 37 Yang CT, Lee MH, Lan RS, Chen JK. Telomerase activity in pleural effusions: Diagnostic significance. J. Clin. Oncol. 1998; 16: 567-73.
38. 38 Duggan BD, Wan MH, Yu MC et al. Detection of ovarian cancer cells: Comparison of a telomerase assay and cytological examination. J. Natl Cancer Int. 1998; 90: 238-42.
39. 39 Iwao T, Hiyama E, Yokoyama T et al. Telomerase activity for the preoperative diagnosis of pancreatic cancer. J. Natl Cancer Inst. 1997; 89: 1621-3.
40. 40 Suehara N, Mizumoto K, Tanaka M et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin. Cancer Res. 1997; 3: 2479-83.